Executive Summary
Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, estimates of 2023 and the forecast for 2024-2029.
The Global Cell and Gene Therapy CDMO market valued at USD 2.54 billion in 2022 is expected to grow at a CAGR of 30.75% during the forecast period of 2024-2029. The global Cell and Gene Therapy CDMO market has been experiencing robust growth and escalating demand, propelled by continuous advancements in cell and gene therapies. With a broadening scope of therapeutic areas and a favourable regulatory environment, the global Cell and Gene Therapy CDMO market is poised for sustained expansion as it plays a pivotal role in the development and commercialization of ground-breaking therapies for various diseases. The global Cell and Gene Therapy CDMO market is expected to grow at an extraordinary rate driven by significant investments from industry players.
The global pipeline of cell and gene therapies has been expanding, covering a wide range of therapeutic areas, including oncology, rare diseases, and genetic disorders. As more therapies advance through clinical trials and toward commercialization, the demand for CDMO services for manufacturing, process development, and scale-up increases.
Global CDMO organisations for cell and gene therapy are expanding, and this is one of the main factors propelling the global Cell and Gene Therapy's overall expansion. With the increasing global demand for advanced cell and gene therapies, CDMOs are proactively setting up production facilities in various locations to meet the changing demands of biotechnology and pharmaceutical companies. These days, CDMOs are essential to the manufacturing of pharmaceuticals. Over the past ten years, CDMOs have grown in prominence due to a more dynamic mergers and acquisition landscape. Serving both local and international markets, there are currently over 600 active Contract Development and Manufacturing Organizations (CDMOs). CDMOs provide specific expertise that helps both "Big Pharma" and smaller inventors to launch products sooner.
The rise of biologics is seen by the number of CDMOs making significant investments in brand-new biomanufacturing facilities. These companies include Boehringer Ingelheim (USD827M investment), Samsung Biologics (USD1.7B investment), Lonza (USD935M expansion), and Fujifilm Diosynth Biotechnologies (USD2B investment).
Additionally, by expanding globally, CDMOs can meet regional regulatory needs, provide customised manufacturing solutions, and improve accessibility for customers who need their services. CDMOs can provide more adaptable and responsive solutions by being present in important worldwide markets. This helps to speed up the development and global commercialization of gene and cell therapies.
One prominent factor restraining the growth of the global Cell and Gene Therapy CDMO market is the high cost of producing viral vectors. As carriers of therapeutic genes into target cells, viral vectors are essential to the development of gene and cell therapies. Viral vector production is a complex procedure that frequently involves specialized techniques, stringent quality control standards, and specialized facilities.
There are now five viral vectors in use for gene therapy. AAV have the biggest market share, followed by lentiviruses, adenoviruses, herpes simplex viruses and retroviruses. The vector manufacturing cost for a single dose might be as high as USD 1-2 million, given the expected price of USD 3-7 million per batch, according to Roland Berger Insights. Therefore, the high cost of producing viral vectors hampers cell and gene therapies from being widely commercialised and made accessible, which limits their uptake and hinders the expansion of the Cell and Gene CDMO market.
Scope of the Report
- The report analyses the Global Cell and Gene Therapy CDMO Market by Value (USD Million).
- The report presents the analysis of Global Cell and Gene Therapy CDMO Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
- The report analyses the Global Cell and Gene Therapy CDMO Market by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies).
- The report analyses the Cell and Gene Therapy CDMO Market by Application (Clinical, Pre-clinical).
- The report analyses the Cell and Gene Therapy CDMO Market by Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Other Indications).
- The report analyses the Cell and Gene Therapy CDMO Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa).
- The report analyses the Cell and Gene Therapy CDMO Market by Country (United States, Canada, United Kingdom, Germany, France, Italy, China, Japan, South Korea, India).
- The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis.
- Also, the major opportunities, trends, drivers and challenges of the industry have been analyzed in the report.
- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Oxford Biomedica, Lonza Group AG, Catalent, Inc., Samsung Biologics, WuXi Biologics, Pfizer CentreOne, Danaher Corporation, Thermo Fisher Scientific Inc., Charles River Laboratories International, Inc., Novartis AG.
Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)
Table of Contents
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
3. Global Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)
3.1 Impact Analysis of Macro Economic Factors on Cell and Gene Therapy CDMO Market
3.2 Cell and Gene Therapy Pipeline
3.3 Clinical AAV Gene Therapies
3.4 Approvals & Drugs by Therapy Area
3.5 Approved Therapies and Pipeline
3.6 Gene Therapy Pipeline
3.7 Gene Therapy Breakdown
3.8 Gene Therapy Pipeline: Most Commonly Targeted Therapeutic Areas
3.9 Cell and Gene Therapy Landscape
3.10 Global Cell and Gene Therapy CDMO Market: Dashboard
3.11 Global Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million)
3.12 Global Cell and Gene Therapy CDMO Market: Recent Development & Approved Cell and Gene Therapies
3.13 Global Cell and Gene Therapy CDMO Market: Recent M&A and Developments
3.14 Impact of COVID-19 on Cell and Gene Therapy CDMO Market
3.15 Global Cell and Gene Therapy CDMO Market Segmentation: By Type
3.15.1 Global Cell and Gene Therapy CDMO Market, By Type Overview
3.15.2 Global Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
3.15.3 Global Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
3.15.4 Global Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
3.16 Global Cell and Gene Therapy CDMO Market Segmentation: By Application
3.16.1 Global Cell and Gene Therapy CDMO Market, By Application Overview
3.16.2 Global Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
3.16.3 Global Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
3.17 Global Cell and Gene Therapy CDMO Market Segmentation: By Indication
3.17.1 Global Cell and Gene Therapy CDMO Market, By Indication Overview
3.17.2 Global Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
3.17.3 Global Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
3.17.4 Global Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
3.17.5 Global Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
4. Global Cell and Gene Therapy CDMO Market: Regional Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)
5.1 Americas Cell and Gene Therapy CDMO Market: Snapshot
5.2 Americas Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million & CAGR)
5.3 Americas Cell and Gene Therapy CDMO Market: Key Factors
5.4 Americas Cell and Gene Therapy CDMO Market: Segment Analysis
5.5 Americas Cell and Gene Therapy CDMO Market Segmentation: By Type
5.5.1 Americas Cell and Gene Therapy CDMO Market, By Type Overview
5.5.2 Americas Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
5.5.3 Americas Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
5.5.4 Americas Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
5.6 Americas Cell and Gene Therapy CDMO Market Segmentation: By Application
5.6.1 Americas Cell and Gene Therapy CDMO Market, By Application Overview
5.6.2 Americas Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
5.6.3 Americas Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
5.7 Americas Cell and Gene Therapy CDMO Market Segmentation: By Indication
5.7.1 Americas Cell and Gene Therapy CDMO Market, By Indication Overview
5.7.2 Americas Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
5.7.3 Americas Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
5.7.4 Americas Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
5.7.5 Americas Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
5.8 Americas Cell and Gene Therapy CDMO Market Segmentation: By Country
5.8.1 Americas Cell and Gene Therapy CDMO Market, By Country Overview
5.8.2 United States Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.8.2.1 United States Cell and Gene Therapy CDMO Market, By Type
5.8.2.2 United States Cell and Gene Therapy CDMO Market, By Application
5.8.2.3 United States Cell and Gene Therapy CDMO Market, By Indication
5.8.3 Canada Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.8.3.1 Canada Cell and Gene Therapy CDMO Market, By Type
5.8.3.2 Canada Cell and Gene Therapy CDMO Market, By Application
5.8.3.3 Canada Cell and Gene Therapy CDMO Market, By Indication
5.8.4 Rest of Americas Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
5.8.4.1 Rest of Americas Cell and Gene Therapy CDMO Market, By Type
5.8.4.2 Rest of Americas Cell and Gene Therapy CDMO Market, By Application
5.8.4.3 Rest of Americas Cell and Gene Therapy CDMO Market, By Indication
6. Europe Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)
6.1 Europe Cell and Gene Therapy CDMO Market: Snapshot
6.2 Europe Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million & CAGR)
6.3 Europe Cell and Gene Therapy CDMO Market: Key Factors
6.4 Europe Cell and Gene Therapy CDMO Market: Segment Analysis
6.5 Europe Cell and Gene Therapy CDMO Market Segmentation: By Type
6.5.1 Europe Cell and Gene Therapy CDMO Market, By Type Overview
6.5.2 Europe Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
6.5.3 Europe Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
6.5.4 Europe Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
6.6 Europe Cell and Gene Therapy CDMO Market Segmentation: By Application
6.6.1 Europe Cell and Gene Therapy CDMO Market, By Application Overview
6.6.2 Europe Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
6.6.3 Europe Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
6.7 Europe Cell and Gene Therapy CDMO Market Segmentation: By Indication
6.7.1 Europe Cell and Gene Therapy CDMO Market, By Indication Overview
6.7.2 Europe Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
6.7.3 Europe Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
6.7.4 Europe Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
6.7.5 Europe Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
6.8 Europe Cell and Gene Therapy CDMO Market Segmentation: By Country
6.8.1 Europe Cell and Gene Therapy CDMO Market, By Country Overview
6.8.2 United Kingdom Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.8.2.1 United Kingdom Cell and Gene Therapy CDMO Market, By Type
6.8.2.2 United Kingdom Cell and Gene Therapy CDMO Market, By Application
6.8.2.3 United Kingdom Cell and Gene Therapy CDMO Market, By Indication
6.8.3 Germany Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.8.3.1 Germany Cell and Gene Therapy CDMO Market, By Type
6.8.3.2 Germany Cell and Gene Therapy CDMO Market, By Application
6.8.3.3 Germany Cell and Gene Therapy CDMO Market, By Indication
6.8.4 France Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.8.4.1 France Cell and Gene Therapy CDMO Market, By Type
6.8.4.2 France Cell and Gene Therapy CDMO Market, By Application
6.8.4.3 France Cell and Gene Therapy CDMO Market, By Indication
6.8.5 Italy Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.8.5.1 Italy Cell and Gene Therapy CDMO Market, By Type
6.8.5.2 Italy Cell and Gene Therapy CDMO Market, By Application
6.8.5.3 Italy Cell and Gene Therapy CDMO Market, By Indication
6.8.6 Rest of Europe Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
6.8.6.1 Rest of Europe Cell and Gene Therapy CDMO Market, By Type
6.8.6.2 Rest of Europe Cell and Gene Therapy CDMO Market, By Application
6.8.6.3 Rest of Europe Cell and Gene Therapy CDMO Market, By Indication
7. Asia Pacific Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)
7.1 Asia Pacific Cell and Gene Therapy CDMO Market: Snapshot
7.2 Asia Pacific Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million & CAGR)
7.3 Asia Pacific Cell and Gene Therapy CDMO Market: Key Factors
7.4 Asia Pacific Cell and Gene Therapy CDMO Market: Segment Analysis
7.5 Asia Pacific Cell and Gene Therapy CDMO Market Segmentation: By Type
7.5.1 Asia Pacific Cell and Gene Therapy CDMO Market, By Type Overview
7.5.2 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
7.5.3 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
7.5.4 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
7.6 Asia Pacific Cell and Gene Therapy CDMO Market Segmentation: By Application
7.6.1 Asia Pacific Cell and Gene Therapy CDMO Market, By Application Overview
7.6.2 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
7.6.3 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
7.7 Asia Pacific Cell and Gene Therapy CDMO Market Segmentation: By Indication
7.7.1 Asia Pacific Cell and Gene Therapy CDMO Market, By Indication Overview
7.7.2 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
7.7.3 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
7.7.4 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
7.7.5 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
7.8 Asia Pacific Cell and Gene Therapy CDMO Market Segmentation: By Country
7.8.1 Asia Pacific Cell and Gene Therapy CDMO Market, By Country Overview
7.8.2 China Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.2.1 China Cell and Gene Therapy CDMO Market, By Type
7.8.2.2 China Cell and Gene Therapy CDMO Market, By Application
7.8.2.3 China Cell and Gene Therapy CDMO Market, By Indication
7.8.3 Japan Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.3.1 Japan Cell and Gene Therapy CDMO Market, By Type
7.8.3.2 Japan Cell and Gene Therapy CDMO Market, By Application
7.8.3.3 Japan Cell and Gene Therapy CDMO Market, By Indication
7.8.4 South Korea Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.4.1 South Korea Cell and Gene Therapy CDMO Market, By Type
7.8.4.2 South Korea Cell and Gene Therapy CDMO Market, By Application
7.8.4.3 South Korea Cell and Gene Therapy CDMO Market, By Indication
7.8.5 India Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.5.1 India Cell and Gene Therapy CDMO Market, By Type
7.8.5.2 India Cell and Gene Therapy CDMO Market, By Application
7.8.5.3 India Cell and Gene Therapy CDMO Market, By Indication
7.8.6 Rest of Asia Pacific Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
7.8.7.1 Rest of Asia Pacific Cell and Gene Therapy CDMO Market, By Type
7.8.7.2 Rest of Asia Pacific Cell and Gene Therapy CDMO Market, By Application
7.8.7.3 Rest of Asia Pacific Cell and Gene Therapy CDMO Market, By Indication
8. Middle East & Africa Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)
8.1 Middle East & Africa Cell and Gene Therapy CDMO Market: Snapshot
8.2 Middle East & Africa Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million & CAGR)
8.3 Middle East & Africa Cell and Gene Therapy CDMO Market: Key Factors
8.4 Middle East & Africa Cell and Gene Therapy CDMO Market: Segment Analysis
8.5 Middle East & Africa Cell and Gene Therapy CDMO Market Segmentation: By Type
8.5.1 Middle East & Africa Cell and Gene Therapy CDMO Market, By Type Overview
8.5.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
8.5.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
8.5.4 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
8.6 Middle East & Africa Cell and Gene Therapy CDMO Market Segmentation: By Application
8.6.1 Middle East & Africa Cell and Gene Therapy CDMO Market, By Application Overview
8.6.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
8.6.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
8.7 Middle East & Africa Cell and Gene Therapy CDMO Market Segmentation: By Indication
8.7.1 Middle East & Africa Cell and Gene Therapy CDMO Market, By Indication Overview
8.7.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
8.7.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
8.7.4 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
8.7.5 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on Global Cell and Gene Therapy CDMO Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Value Chain Analysis
10.2 Porter's Five Forces Model
11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Competitive Positioning of Oxford Biomedica's Viral Vector Offering
11.3 Market Position Matrix
11.4 Market Share Analysis of Cell and Gene Therapy CDMO Market
11.5 Company Profiles
11.5.1 Oxford Biomedica
11.5.2 Lonza Group AG
11.5.3 Catalent, Inc.
11.5.4 Samsung Biologics
11.5.5 WuXi Biologics
11.5.6 Pfizer CentreOne
11.5.7 Danaher Corporation
11.5.8 Thermo Fisher Scientific Inc.
11.5.9 Charles River Laboratories International, Inc.
11.5.10 Novartis AG
List of Figures
Figure 1: Cell & Gene Therapy Assets in Global Development
Figure 2: Genetically Modified Cell Therapy Breakdown
Figure 3: CAR-T Breakdown
Figure 4: Global Cell and Gene Therapy CDMO Market Size, By Value, 2019-2022 (USD Million)
Figure 5: Global Cell and Gene Therapy CDMO Market Size, By Value, 2023-2029 (USD Million)
Figure 6: Global Cell and Gene Therapy CDMO Market CAGR (%), By Value, 2019-2022, 2024-2029
Figure 7: Global Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 8: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Cell Therapy, 2019-2029 (USD Million)
Figure 9: Global Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 10: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Gene Therapy, 2019-2029 (USD Million)
Figure 11: Global Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 12: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Gene-modified Cell Therapies, 2019-2029 (USD Million)
Figure 13: Global Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 14: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Clinical, 2019-2029 (USD Million)
Figure 15: Global Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 16: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Pre-clinical, 2019-2029 (USD Million)
Figure 17: Global Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 18: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Oncology Diseases, 2019-2029 (USD Million)
Figure 19: Global Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 20: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Infectious Diseases, 2019-2029 (USD Million)
Figure 21: Global Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
Figure 22: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Neurological Disorder, 2019-2029 (USD Million)
Figure 23: Global Cell and Gene Therapy CDMO Market Size, Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
Figure 24: Global Cell and Gene Therapy CDMO Market Absolute Opportunity, By Other Indications, 2019-2029 (USD Million)
Figure 25: Americas Cell and Gene Therapy CDMO Market Size, By Value, 2019H-2029F (USD Million)
Figure 26: Americas Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 27: Americas Cell and Gene Therapy CDMO Market, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 28: Americas Cell and Gene Therapy CDMO Market, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 29: Americas Cell and Gene Therapy CDMO Market, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 30: Americas Cell and Gene Therapy CDMO Market, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 31: Americas Cell and Gene Therapy CDMO Market, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 32: Americas Cell and Gene Therapy CDMO Market, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 33: Americas Cell and Gene Therapy CDMO Market, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 34: Americas Cell and Gene Therapy CDMO Market, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
Figure 35: Americas Cell and Gene Therapy CDMO Market, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
Figure 36: United States Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 37: United States Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 38: United States Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 39: United States Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 40: United States Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 41: Canada Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 42: Canada Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 43: Canada Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 44: Canada Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 45: Canada Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 46: Rest of Americas Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 47: Rest of Americas Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 48: Rest of Americas Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 49: Rest of Americas Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 50: Rest of Americas Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 51: Europe Cell and Gene Therapy CDMO Market Size, By Value, 2019H-2029F (USD Million)
Figure 52: Europe Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 53: Europe Cell and Gene Therapy CDMO Market, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 54: Europe Cell and Gene Therapy CDMO Market, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 55: Europe Cell and Gene Therapy CDMO Market, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 56: Europe Cell and Gene Therapy CDMO Market, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 57: Europe Cell and Gene Therapy CDMO Market, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 58: Europe Cell and Gene Therapy CDMO Market, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 59: Europe Cell and Gene Therapy CDMO Market, Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 60: Europe Cell and Gene Therapy CDMO Market, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
Figure 61: Europe Cell and Gene Therapy CDMO Market, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
Figure 62: United Kingdom Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 63: United Kingdom Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 64: United Kingdom Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 65: United Kingdom Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 66: United Kingdom Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 67: Germany Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 68: Germany Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 69: Germany Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 70: Germany Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 71: Germany Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 72: France Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 73: France Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 74: France Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 75: France Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 76: France Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 77: Italy Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 78: Italy Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 79: Italy Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 80: Italy Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 81: Italy Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 82: Rest of Europe Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 83: Rest of Europe Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 84: Rest of Europe Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 85: Rest of Europe Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 86: Rest of Europe Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 87: Asia Pacific Cell and Gene Therapy CDMO Market Size, By Value, 2019H-2029F (USD Million)
Figure 88: Asia Pacific Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 89: Asia Pacific Cell and Gene Therapy CDMO Market, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 90: Asia Pacific Cell and Gene Therapy CDMO Market, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 91: Asia Pacific Cell and Gene Therapy CDMO Market, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)
Figure 92: Asia Pacific Cell and Gene Therapy CDMO Market, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 93: Asia Pacific Cell and Gene Therapy CDMO Market, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 94: Asia Pacific Cell and Gene Therapy CDMO Market, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 95: Asia Pacific Cell and Gene Therapy CDMO Market, Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 96: Asia Pacific Cell and Gene Therapy CDMO Market, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
Figure 97: Asia Pacific Cell and Gene Therapy CDMO Market, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
Figure 98: China Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 99: China Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 100: China Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 101: China Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 102: China Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 103: Japan Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 104: Japan Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 105: Japan Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 106: Japan Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 107: Japan Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 108: South Korea Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 109: South Korea Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 110: South Korea Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 111: South Korea Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 112: South Korea Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 113: India Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 114: India Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 115: India Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 116: India Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 117: India Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 118: Rest of Asia Pacific Cell and Gene Therapy CDMO Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 119: Rest of Asia Pacific Cell and Gene Therapy CDMO Market Value, By Application, 2022 (USD Million)
Figure 120: Rest of Asia Pacific Cell and Gene Therapy CDMO Market Share, By Type, By Value, 2022 (%)
Figure 121: Rest of Asia Pacific Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 122: Rest of Americas Cell and Gene Therapy CDMO Market Share, By Indication, 2022 (%)
Figure 123: Middle east & Africa Cell and Gene Therapy CDMO Market Size, By Value, 2019H-2029F (USD Million)
Figure 124: Middle east & Africa Cell and Gene Therapy CDMO Market Share, By Application, 2022 (%)
Figure 125: Middle east & Africa Cell and Gene Therapy CDMO Market, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 126: Middle east & Africa Cell and Gene Therapy CDMO Market, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 127: Middle East & Africa Cell and Gene Therapy CDMO Market, By Gene-modified Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)
Figure 128: Middle east & Africa Cell and Gene Therapy CDMO Market, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 129: Middle East & Africa Cell and Gene Therapy CDMO Market, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)
Figure 130: Middle east & Africa Cell and Gene Therapy CDMO Market, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 131: Middle east & Africa Cell and Gene Therapy CDMO Market, Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)
Figure 132: Middle east & Africa Cell and Gene Therapy CDMO Market, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)
Figure 133: Middle East & Africa Cell and Gene Therapy CDMO Market, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)
Figure 134: Global Impact of Drivers and Restraints
Figure 135: Market Share of Prominent Companies of Cell and Gene Therapy CDMO Market, 2022 (%)
Figure 136: Oxford Biomedica Revenues, 2020-2022 (USD Million)
Figure 137: Oxford Biomedica, Revenue By Business Segment, 2022 (%)
Figure 138: Oxford Biomedica, Revenue By Geographic Segment, 2022 (%)
Figure 139: Oxford Biomedica, Largest Shareholders, 2022 (%)
Figure 140: Lonza Group AG Revenues, 2020-2022 (USD Million)
Figure 141: Lonza Group AG Revenue By Customer Group, 2022 (%)
Figure 142: Lonza Group AG, By Infrastructure, 2022
Figure 143: Lonza Group AG, CDMO Sales By Customer Location , 2022 (%)
Figure 144: Lonza Group AG, CDMO Sales By Customer Type , 2022 (%)
Figure 145: Lonza Group AG, Distribution of CDMO Customers By Sales, 2022 (%)
Figure 146: Catalent, Inc. Revenues, 2020-2022 (USD Million)
Figure 147: Catalent, Inc. Revenue By Business Segment, 2022 (%)
Figure 148: Catalent, Inc. Revenue By Geographic Segment, 2022 (%)
Figure 149: Samsung Biologics Revenues, 2020-2022 (USD Million)
Figure 150: Samsung Biologics Revenue By Business Segment, 2022 (%)
Figure 151: Samsung Biologics Revenue By Geographic Segment, 2022 (%)
Figure 152: WuXi Biologics Revenues, 2020-2022 (USD Million)
Figure 153: WuXi Biologics Revenue By Business Segment, 2022 (%)
Figure 154: WuXi Biologics Revenue By Geographic Segment, 2022 (%)
Figure 155: Pfizer CentreOne Revenues, 2020-2022 (USD Million)
Figure 156: Pfizer CentreOne Revenue By Geographic Segment, 2022 (%)
Figure 157: Danaher Corporation Revenues, 2020-2022 (USD Million)
Figure 158: Danaher Corporation Revenue, By Business Segments, 2022 (%)
Figure 159: Danaher Corporation Revenue, By Geographic Segments, 2022 (%)
Figure 160: Thermo Fisher Scientific Inc. Revenues, 2020-2022 (USD Million)
Figure 161: Thermo Fisher Scientific Inc. Revenue By Business Segment, 2022 (%)
Figure 162: Thermo Fisher Scientific Inc. Revenue By Geographic Segment, 2022 (%)
Figure 163: Charles River Laboratories International, Inc. Revenues, 2020-2022 (USD Million)
Figure 164: Charles River Laboratories International, Inc. Revenue By Business Segment, 2022 (%)
Figure 165: Charles River Laboratories International, Inc. Revenue By Geographic Segment, 2022 (%)
Figure 166: Novartis AG Revenues, 2020-2022 (USD Million)
Figure 167: Novartis AG Revenue By Business Segment, 2022 (%)
Figure 168: Novartis AG Revenue By Geographic Segment, 2022 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: OXB's Internal Cell and Gene Therapy Pipeline
Table A3: Clinical AAV Gene Therapies for Genetic Neurological Disorders
Table A4: FDA NME Approvals, 2019-2022
Table A5: Drugs by Therapy Area
Table A6: Approved Gene, Cell, and RNA Therapies Globally, for Clinical Use
Table A7: Pipeline Therapies by Category
Table A8: Approved Gene, Cell, and RNA Therapies Globally, for Clinical Use
Table A9: Number of Therapies from Pre-clinical through Pre-registration
Table A10: Therapies in the Clinic (excludes preclinical development)
Table A11: Cell and Gene Thera
Global Gene Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 111
According to our LPI (LP Information) latest study, the global Gene Therapy market size was valued at US$ 6923.7 million in 2023. With growing demand in downstream market, the Gene Therapy is forecast to a readjusted size of US$ 40340 million by 2030 with a CAGR of 28.6% during review period.
The research report highlights the growth potential of the global Gene Therapy market. Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducin......
Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Hemophilia Gene Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Hemophilia Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hemophilia Gene Therapy market. Hemophilia Gene Therapy are expected to show stable growth in the future market. However, produc......
Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)
Published: 01-Jan-2024 Price: US 2450 Onwards Pages: 260
Executive Summary
Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, es......
Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 88
According to our (Global Info Research) latest study, the global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode pr......
Global Gene Expression Analysis Market Status and Outlook 2023-2028
Published: 26-Dec-2023 Price: US 3160 Onwards Pages: 102
Gene expression analyses study the occurrence or activity of the formation of a gene product from its coding gene. It is a sensitive indicator of biological activity wherein a changing gene expression pattern is reflected in a change of biological process.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
Global Gene Expression Analysis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 125
Market Overview of Global Gene Expression Analysis market:
According to our latest research, the global Gene Expression Analysis market looks promising in the next 5 years. As of 2022, the global Gene Expression Analysis market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
Global Animal Genetics Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 120
Report Overview:
Animal Genetics is a branch of genetics that studies heredity and variation chiefly in farm animals but also in domestic and wild animals. It is based on general genetic principles and concepts, and it mainly uses the hybrid, cytological, population, ontogenetic, mathematical-statistical, and twin methods of general genetics.
Animal breeding or genetics is the area of science where experts are trying to steer the frequency of certain genes by combining the most super......
Global Animal Genetics Market Status and Outlook 2023-2028
Published: 24-Nov-2023 Price: US 3160 Onwards Pages: 105
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
D......
Gene Therapy Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 450
Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene therapy deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of gene therapy deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter gene therapy deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
